Evidence map›Paper›PMID 39941791›Full record

ArticleCancers2025

An Accelerated Spectroscopic MRI Metabolite Quantification Based on a Deep Learning Method for Radiation Therapy Planning in Brain Tumor Patients.

Alexander S Giuffrida, Karthik Ramesh, Sulaiman Sheriff, Andrew A Maudsley, Brent D Weinberg, Lee A D Cooper, Hyunsuk Shim

Registry-linked trialAbstract read
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03137888 (Pilot Study of Spectroscopic MRI-Guided, Dose-Escalated Radiation Therapy for Newly-Diagnosed Glioblastoma), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03137888 phase2completednot on this map

Pilot Study of Spectroscopic MRI-Guided, Dose-Escalated Radiation Therapy for Newly-Diagnosed Glioblastoma

TypeinterventionalSponsorEmory UniversityRan2017 to 2024Enrolled30ConditionsGlioblastoma, GliosarcomaArmsDose-Escalated Radiation Therapy, Spectroscopic Magnetic Resonance Imaging, Temozolomide
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alexander S GiuffridaDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Karthik RameshDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.
Sulaiman SheriffDepartment of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, FL 45056, USA.ORCID 0000-0002-4792-4484
Andrew A MaudsleyDepartment of Radiation Oncology, Miller School of Medicine, University of Miami, Miami, FL 45056, USA.ORCID 0000-0001-7653-3063
Brent D WeinbergWinship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0002-7992-1747
Lee A D CooperDepartment of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL 60657, USA.ORCID 0000-0002-3504-4965
Hyunsuk ShimDepartment of Radiation Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA.ORCID 0000-0001-8313-2612

Funding

Improved whole-brain spectroscopic MRI for radiation therapy planningU01CA264039 · NCI · EMORY UNIVERSITY · PI Lee Cooper, Eric Albert Mellon · 2022 to 2026
$3.1M
Improved Whole-Brain Spectroscopic MRI for Radiation Treatment PlanningU01EB028145 · NIBIB · EMORY UNIVERSITY · PI COOPER, LEE, HAN, HUI · 2018 to 2020
$2.4M
NCI NIH HHS U01 CA264039NIBIB NIH HHS U01 EB028145NIH HHS 1U01CA264039-22A1
6 · The paper itself

Abstract

backgroundSpectroscopic MRI (sMRI) is a quantitative imaging technique that maps infiltrated tumors in the brain without contrast injections. In a previous study (NCT03137888), sMRI-guided radiation treatment extended patient survival, showing promise for clinical translation. The spectral fitting of individual voxels in an sMRI dataset generate metabolite concentration maps that guide treatment. The established spectral analysis methods use iterative least-squares fitting (FITT) that are computationally demanding. This study compares the performance of NNFit, a neural network-based, accelerated spectral fitting model, to the established FITT for metabolite quantification and radiation treatment planning.

methodsNNFit is a self-supervised deep learning model trained on 50 ms echo-time (TE) sMRI data to estimate metabolite levels of choline (Cho), creatine (Cr), and NAA. We trained the model on 30 GBM patients (56 scans) and tested it on 17 GBM patients (29 scans). NNFit's performance was compared to the FITT using structural similarity indices (SSIM) and the Dice coefficient.

resultsNNFit significantly improved processing speed while maintaining strong agreement with FITT. The radiation target volumes defined by Cho/NAA ≥ 2x were visually comparable, with fewer artifacts in NNFit. Structural similarity indices (SSIM) indicated minimal bias and high consistency across methods.

conclusionsThis study highlights NNFit's potential for rapid, accurate, and artifact-reduced metabolic imaging, enabling faster radiotherapy planning.

Indexed as

deep learningglioblastomaMR spectroscopyradiation treatmentspectroscopic MRI (sMRI)

Identifiers

PMID39941791
PMCPMC11816355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.